NCT05763199
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with ovarian, fallopian tube, or peritoneal cancer that was confirmed by a tissue or cell sample, including various types of this cancer
- Your cancer was diagnosed at any stage (Stage I through IV)
- Your treatment plan includes standard chemotherapy (a platinum-based drug plus a taxane drug) after surgery, and you may also have received chemotherapy before surgery
- You are 18 years of age or older
- You speak English or Spanish
- You are well enough to carry out basic daily activities (your doctor will assess this)
- Your blood counts and organ function (including white blood cells, platelets, liver, and kidneys) meet certain minimum levels as determined by a blood test (confirm with trial site)
- If you could become pregnant, you agree to use effective birth control during the study and for at least 5 months after the last dose, and agree not to donate eggs during this time
- You are willing and able to sign a consent form
- If you are HIV-positive, you may still be eligible if your HIV is well-controlled on medication, you have no active infections requiring preventive treatment, and your immune cell count and virus levels are within acceptable ranges (confirm with trial site)
Who may not be able to join:
- You have a history of allergic reactions to mushrooms
- You have a history of allergic reactions to dextrin (a type of starch)
- You have a history of allergic reactions to rapeseed oil
- You have a history of allergic reactions to corn
- You currently take supplements made from mushrooms or similar fungi (eating whole mushrooms in your regular diet is fine)
- You are currently taking or have taken immune-suppressing medications (such as prednisone or similar drugs) within the past 3 months, with some exceptions for low-dose or topical uses (confirm with trial site)
- You have an uncontrolled illness, active infection, serious heart condition, or a mental health or personal situation that could affect your safety or ability to follow the study requirements
- You are unable to swallow the study pill or placebo
- You have had your stomach surgically removed or have a condition that affects how your body absorbs nutrients
- You are currently pregnant or breastfeeding
- You have any condition that prevents you from understanding or signing a consent form
- You have any other medical condition that your doctor believes could affect your safety or ability to participate in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of participants consent and randomized to taking AHCC or placebo during adjuvant chemotherapy compared to to total number of ovarian cancer patients eligible for the trial following prescreening and participation invitation.; Time required to randomize 20 participants; Proportion of participants that complete study treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.